APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Sustained Release Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharma Sustained Release Agent Market Analysis and Forecast 2026-2032

21 December 2025206 pages

Choose your research edition.

Industry ResearchPharma Sustained Release Agent Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Sustained Release Agent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Pharma Sustained Release Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Sustained Release Agent Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Sustained Release Agent Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Pharma Sustained Release Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharma Sustained Release Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharma Sustained Release Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharma Sustained Release Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharma Sustained Release Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pharma Sustained Release Agent include Janssen Pharmaceuticals, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Novartis AG, Merck KGaA, Mylan N.V., Pfizer, GlaxoSmithKline and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharma Sustained Release Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharma Sustained Release Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Pharma Sustained Release Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma Sustained Release Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharma Sustained Release Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharma Sustained Release Agent sales, projected growth trends, production technology, application and end-user industry.

Pharma Sustained Release Agent Segment by Company

Janssen Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Novartis AG

Merck KGaA

Mylan N.V.

Pfizer

GlaxoSmithKline

AstraZeneca

Valeant Pharmaceuticals International

Mayne Pharma Group

International Flavors & Fragrances

Gattefosse

Evonik Industries

Croda International

BASF

Ashland Global

Allergan

Pharma Sustained Release Agent Segment by Type

Sugars

Gelatin

Minerals

Chitosan

Polymers

Pharma Sustained Release Agent Segment by Application

Pharmaceutical

Health Care

Others

Pharma Sustained Release Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Sustained Release Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Sustained Release Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Sustained Release Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pharma Sustained Release Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharma Sustained Release Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Sustained Release Agent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharma Sustained Release Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sugars Major Manufacturers Table 3. Gelatin Major Manufacturers Table 4. Minerals Major Manufacturers Table 5. Chitosan Major Manufacturers Table 6. Polymers Major Manufacturers Table 7. Global Pharma Sustained Release Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharmaceutical Major Manufacturers Table 9. Health Care Major Manufacturers Table 10. Others Major Manufacturers Table 11. Pharma Sustained Release Agent Industry Trends Table 12. Pharma Sustained Release Agent Industry Drivers Table 13. Pharma Sustained Release Agent Industry Opportunities and Challenges Table 14. Pharma Sustained Release Agent Industry Restraints Table 15. Global Pharma Sustained Release Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Pharma Sustained Release Agent Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Pharma Sustained Release Agent Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Pharma Sustained Release Agent Revenue Market Share by Region (2021-2026) Table 19. Global Pharma Sustained Release Agent Revenue Market Share by Region (2027-2032) Table 20. Global Pharma Sustained Release Agent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 21. Global Pharma Sustained Release Agent Sales by Region (2021-2026) & (k tons) Table 22. Global Pharma Sustained Release Agent Sales by Region (2027-2032) & (k tons) Table 23. Global Pharma Sustained Release Agent Sales Market Share by Region (2021-2026) Table 24. Global Pharma Sustained Release Agent Sales Market Share by Region (2027-2032) Table 25. Global Pharma Sustained Release Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pharma Sustained Release Agent Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Pharma Sustained Release Agent Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Pharma Sustained Release Agent Sales Market Share by Manufacturers (2021-2026) Table 29. Global Pharma Sustained Release Agent Sales Price (US$/ton) of Manufacturers (2021-2026) Table 30. Global Pharma Sustained Release Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Pharma Sustained Release Agent Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Pharma Sustained Release Agent Manufacturers, Product Type & Application Table 33. Global Pharma Sustained Release Agent Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Pharma Sustained Release Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Pharma Sustained Release Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Pharma Sustained Release Agent Revenue Market Share by Type (2021-2026) Table 40. Global Pharma Sustained Release Agent Revenue Market Share by Type (2027-2032) Table 41. Global Pharma Sustained Release Agent Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 42. Global Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 43. Global Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 44. Global Pharma Sustained Release Agent Sales Market Share by Type (2021-2026) Table 45. Global Pharma Sustained Release Agent Sales Market Share by Type (2027-2032) Table 46. Global Pharma Sustained Release Agent Price by Type (2021-2026) & (US$/ton) Table 47. Global Pharma Sustained Release Agent Price by Type (2027-2032) & (US$/ton) Table 48. Global Pharma Sustained Release Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Pharma Sustained Release Agent Revenue Market Share by Application (2021-2026) Table 52. Global Pharma Sustained Release Agent Revenue Market Share by Application (2027-2032) Table 53. Global Pharma Sustained Release Agent Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 54. Global Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 55. Global Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 56. Global Pharma Sustained Release Agent Sales Market Share by Application (2021-2026) Table 57. Global Pharma Sustained Release Agent Sales Market Share by Application (2027-2032) Table 58. Global Pharma Sustained Release Agent Price by Application (2021-2026) & (US$/ton) Table 59. Global Pharma Sustained Release Agent Price by Application (2027-2032) & (US$/ton) Table 60. Janssen Pharmaceuticals Company Information Table 61. Janssen Pharmaceuticals Business Overview Table 62. Janssen Pharmaceuticals Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 63. Janssen Pharmaceuticals Pharma Sustained Release Agent Product Portfolio Table 64. Janssen Pharmaceuticals Recent Development Table 65. Teva Pharmaceutical Industries Company Information Table 66. Teva Pharmaceutical Industries Business Overview Table 67. Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Industries Pharma Sustained Release Agent Product Portfolio Table 69. Teva Pharmaceutical Industries Recent Development Table 70. Sun Pharmaceutical Industries Company Information Table 71. Sun Pharmaceutical Industries Business Overview Table 72. Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Sun Pharmaceutical Industries Pharma Sustained Release Agent Product Portfolio Table 74. Sun Pharmaceutical Industries Recent Development Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Novartis AG Pharma Sustained Release Agent Product Portfolio Table 79. Novartis AG Recent Development Table 80. Merck KGaA Company Information Table 81. Merck KGaA Business Overview Table 82. Merck KGaA Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Merck KGaA Pharma Sustained Release Agent Product Portfolio Table 84. Merck KGaA Recent Development Table 85. Mylan N.V. Company Information Table 86. Mylan N.V. Business Overview Table 87. Mylan N.V. Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Mylan N.V. Pharma Sustained Release Agent Product Portfolio Table 89. Mylan N.V. Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Pfizer Pharma Sustained Release Agent Product Portfolio Table 94. Pfizer Recent Development Table 95. GlaxoSmithKline Company Information Table 96. GlaxoSmithKline Business Overview Table 97. GlaxoSmithKline Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. GlaxoSmithKline Pharma Sustained Release Agent Product Portfolio Table 99. GlaxoSmithKline Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. AstraZeneca Pharma Sustained Release Agent Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Valeant Pharmaceuticals International Company Information Table 106. Valeant Pharmaceuticals International Business Overview Table 107. Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. Valeant Pharmaceuticals International Pharma Sustained Release Agent Product Portfolio Table 109. Valeant Pharmaceuticals International Recent Development Table 110. Mayne Pharma Group Company Information Table 111. Mayne Pharma Group Business Overview Table 112. Mayne Pharma Group Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. Mayne Pharma Group Pharma Sustained Release Agent Product Portfolio Table 114. Mayne Pharma Group Recent Development Table 115. International Flavors & Fragrances Company Information Table 116. International Flavors & Fragrances Business Overview Table 117. International Flavors & Fragrances Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. International Flavors & Fragrances Pharma Sustained Release Agent Product Portfolio Table 119. International Flavors & Fragrances Recent Development Table 120. Gattefosse Company Information Table 121. Gattefosse Business Overview Table 122. Gattefosse Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. Gattefosse Pharma Sustained Release Agent Product Portfolio Table 124. Gattefosse Recent Development Table 125. Evonik Industries Company Information Table 126. Evonik Industries Business Overview Table 127. Evonik Industries Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 128. Evonik Industries Pharma Sustained Release Agent Product Portfolio Table 129. Evonik Industries Recent Development Table 130. Croda International Company Information Table 131. Croda International Business Overview Table 132. Croda International Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 133. Croda International Pharma Sustained Release Agent Product Portfolio Table 134. Croda International Recent Development Table 135. BASF Company Information Table 136. BASF Business Overview Table 137. BASF Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 138. BASF Pharma Sustained Release Agent Product Portfolio Table 139. BASF Recent Development Table 140. Ashland Global Company Information Table 141. Ashland Global Business Overview Table 142. Ashland Global Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 143. Ashland Global Pharma Sustained Release Agent Product Portfolio Table 144. Ashland Global Recent Development Table 145. Allergan Company Information Table 146. Allergan Business Overview Table 147. Allergan Pharma Sustained Release Agent Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 148. Allergan Pharma Sustained Release Agent Product Portfolio Table 149. Allergan Recent Development Table 150. North America Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 153. North America Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 154. North America Pharma Sustained Release Agent Sales Price by Type (2021-2026) & (US$/ton) Table 155. North America Pharma Sustained Release Agent Sales Price by Type (2027-2032) & (US$/ton) Table 156. North America Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 159. North America Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 160. North America Pharma Sustained Release Agent Sales Price by Application (2021-2026) & (US$/ton) Table 161. North America Pharma Sustained Release Agent Sales Price by Application (2027-2032) & (US$/ton) Table 162. North America Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Pharma Sustained Release Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Pharma Sustained Release Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 166. North America Pharma Sustained Release Agent Sales by Country (2021-2026) & (k tons) Table 167. North America Pharma Sustained Release Agent Sales by Country (2027-2032) & (k tons) Table 168. North America Pharma Sustained Release Agent Sales Price by Country (2021-2026) & (US$/ton) Table 169. North America Pharma Sustained Release Agent Sales Price by Country (2027-2032) & (US$/ton) Table 170. United States Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 171. Canada Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 172. Mexico Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 173. Europe Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 174. Europe Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 175. Europe Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 176. Europe Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 177. Europe Pharma Sustained Release Agent Sales Price by Type (2021-2026) & (US$/ton) Table 178. Europe Pharma Sustained Release Agent Sales Price by Type (2027-2032) & (US$/ton) Table 179. Europe Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 180. Europe Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 181. Europe Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 182. Europe Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 183. Europe Pharma Sustained Release Agent Sales Price by Application (2021-2026) & (US$/ton) Table 184. Europe Pharma Sustained Release Agent Sales Price by Application (2027-2032) & (US$/ton) Table 185. Europe Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Europe Pharma Sustained Release Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Europe Pharma Sustained Release Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Europe Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 189. Europe Pharma Sustained Release Agent Sales by Country (2021-2026) & (k tons) Table 190. Europe Pharma Sustained Release Agent Sales by Country (2027-2032) & (k tons) Table 191. Europe Pharma Sustained Release Agent Sales Price by Country (2021-2026) & (US$/ton) Table 192. Europe Pharma Sustained Release Agent Sales Price by Country (2027-2032) & (US$/ton) Table 193. Germany Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 194. France Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 195. U.K. Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 196. Italy Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 197. Russia Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 198. Spain Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 199. Netherlands Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 200. Switzerland Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 201. Sweden Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 202. Poland Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 203. China Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 204. China Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 205. China Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 206. China Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 207. China Pharma Sustained Release Agent Sales Price by Type (2021-2026) & (US$/ton) Table 208. China Pharma Sustained Release Agent Sales Price by Type (2027-2032) & (US$/ton) Table 209. China Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 210. China Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 211. China Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 212. China Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 213. China Pharma Sustained Release Agent Sales Price by Application (2021-2026) & (US$/ton) Table 214. China Pharma Sustained Release Agent Sales Price by Application (2027-2032) & (US$/ton) Table 215. Asia Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 216. Asia Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 217. Asia Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 218. Asia Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 219. Asia Pharma Sustained Release Agent Sales Price by Type (2021-2026) & (US$/ton) Table 220. Asia Pharma Sustained Release Agent Sales Price by Type (2027-2032) & (US$/ton) Table 221. Asia Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 222. Asia Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 223. Asia Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 224. Asia Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 225. Asia Pharma Sustained Release Agent Sales Price by Application (2021-2026) & (US$/ton) Table 226. Asia Pharma Sustained Release Agent Sales Price by Application (2027-2032) & (US$/ton) Table 227. Asia Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. Asia Pharma Sustained Release Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. Asia Pharma Sustained Release Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. Asia Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 231. Asia Pharma Sustained Release Agent Sales by Country (2021-2026) & (k tons) Table 232. Asia Pharma Sustained Release Agent Sales by Country (2027-2032) & (k tons) Table 233. Asia Pharma Sustained Release Agent Sales Price by Country (2021-2026) & (US$/ton) Table 234. Asia Pharma Sustained Release Agent Sales Price by Country (2027-2032) & (US$/ton) Table 235. Japan Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 236. South Korea Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 237. India Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 238. Australia Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 239. Taiwan Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 240. Southeast Asia Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 241. SAMEA Pharma Sustained Release Agent Revenue by Type (2021-2026) & (US$ Million) Table 242. SAMEA Pharma Sustained Release Agent Revenue by Type (2027-2032) & (US$ Million) Table 243. SAMEA Pharma Sustained Release Agent Sales by Type (2021-2026) & (k tons) Table 244. SAMEA Pharma Sustained Release Agent Sales by Type (2027-2032) & (k tons) Table 245. SAMEA Pharma Sustained Release Agent Sales Price by Type (2021-2026) & (US$/ton) Table 246. SAMEA Pharma Sustained Release Agent Sales Price by Type (2027-2032) & (US$/ton) Table 247. SAMEA Pharma Sustained Release Agent Revenue by Application (2021-2026) & (US$ Million) Table 248. SAMEA Pharma Sustained Release Agent Revenue by Application (2027-2032) & (US$ Million) Table 249. SAMEA Pharma Sustained Release Agent Sales by Application (2021-2026) & (k tons) Table 250. SAMEA Pharma Sustained Release Agent Sales by Application (2027-2032) & (k tons) Table 251. SAMEA Pharma Sustained Release Agent Sales Price by Application (2021-2026) & (US$/ton) Table 252. SAMEA Pharma Sustained Release Agent Sales Price by Application (2027-2032) & (US$/ton) Table 253. SAMEA Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 254. SAMEA Pharma Sustained Release Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 255. SAMEA Pharma Sustained Release Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 256. SAMEA Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 257. SAMEA Pharma Sustained Release Agent Sales by Country (2021-2026) & (k tons) Table 258. SAMEA Pharma Sustained Release Agent Sales by Country (2027-2032) & (k tons) Table 259. SAMEA Pharma Sustained Release Agent Sales Price by Country (2021-2026) & (US$/ton) Table 260. SAMEA Pharma Sustained Release Agent Sales Price by Country (2027-2032) & (US$/ton) Table 261. Brazil Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 262. Argentina Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 263. Chile Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 264. Colombia Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 265. Peru Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 266. Saudi Arabia Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 267. Israel Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 268. UAE Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 269. Turkey Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 270. Iran Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 271. Egypt Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Table 272. Key Raw Materials Table 273. Raw Materials Key Suppliers Table 274. Pharma Sustained Release Agent Distributors List Table 275. Pharma Sustained Release Agent Customers List Table 276. Research Programs/Design for This Report Table 277. Authors List of This Report Table 278. Secondary Sources Table 279. Primary Sources List of Figures Figure 1. Pharma Sustained Release Agent Image Figure 2. Global Pharma Sustained Release Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Sustained Release Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sugars Image Figure 5. Gelatin Image Figure 6. Minerals Image Figure 7. Chitosan Image Figure 8. Polymers Image Figure 9. Global Pharma Sustained Release Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Pharma Sustained Release Agent Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharmaceutical Image Figure 12. Health Care Image Figure 13. Others Image Figure 14. Global Pharma Sustained Release Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharma Sustained Release Agent Revenue (2021-2032) & (US$ Million) Figure 16. Global Pharma Sustained Release Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Pharma Sustained Release Agent Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Pharma Sustained Release Agent Revenue Market Share by Region (2021-2032) Figure 19. Global Pharma Sustained Release Agent Sales (2021-2032) & (k tons) Figure 20. Global Pharma Sustained Release Agent Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 21. Global Pharma Sustained Release Agent Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Pharma Sustained Release Agent Sales YoY (2021-2032) & (k tons) Figure 23. Europe Pharma Sustained Release Agent Sales YoY (2021-2032) & (k tons) Figure 24. China Pharma Sustained Release Agent Sales YoY (2021-2032) & (k tons) Figure 25. Asia (Excluding China) Pharma Sustained Release Agent Sales YoY (2021-2032) & (k tons) Figure 26. South America, Middle East and Africa Pharma Sustained Release Agent Sales YoY (2021-2032) & (k tons) Figure 27. Global Pharma Sustained Release Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Pharma Sustained Release Agent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Pharma Sustained Release Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Pharma Sustained Release Agent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pharma Sustained Release Agent Revenue Market Share by Type (2021-2032) Figure 33. Global Pharma Sustained Release Agent Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 34. Global Pharma Sustained Release Agent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Pharma Sustained Release Agent Sales Market Share by Type (2021-2032) Figure 36. Global Pharma Sustained Release Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Pharma Sustained Release Agent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pharma Sustained Release Agent Revenue Market Share by Application (2021-2032) Figure 39. Global Pharma Sustained Release Agent Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 40. Global Pharma Sustained Release Agent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Pharma Sustained Release Agent Sales Market Share by Application (2021-2032) Figure 42. North America Pharma Sustained Release Agent Revenue Share by Type (2021-2032) Figure 43. North America Pharma Sustained Release Agent Sales Share by Type (2021-2032) Figure 44. North America Pharma Sustained Release Agent Revenue Share by Application (2021-2032) Figure 45. North America Pharma Sustained Release Agent Sales Share by Application (2021-2032) Figure 46. North America Pharma Sustained Release Agent Revenue Share by Country (2021-2032) Figure 47. North America Pharma Sustained Release Agent Sales Share by Country (2021-2032) Figure 48. Europe Pharma Sustained Release Agent Revenue Share by Type (2021-2032) Figure 49. Europe Pharma Sustained Release Agent Sales Share by Type (2021-2032) Figure 50. Europe Pharma Sustained Release Agent Revenue Share by Application (2021-2032) Figure 51. Europe Pharma Sustained Release Agent Sales Share by Application (2021-2032) Figure 52. Europe Pharma Sustained Release Agent Revenue Share by Country (2021-2032) Figure 53. Europe Pharma Sustained Release Agent Sales Share by Country (2021-2032) Figure 54. China Pharma Sustained Release Agent Revenue Share by Type (2021-2032) Figure 55. China Pharma Sustained Release Agent Sales Share by Type (2021-2032) Figure 56. China Pharma Sustained Release Agent Revenue Share by Application (2021-2032) Figure 57. China Pharma Sustained Release Agent Sales Share by Application (2021-2032) Figure 58. Asia Pharma Sustained Release Agent Revenue Share by Type (2021-2032) Figure 59. Asia Pharma Sustained Release Agent Sales Share by Type (2021-2032) Figure 60. Asia Pharma Sustained Release Agent Revenue Share by Application (2021-2032) Figure 61. Asia Pharma Sustained Release Agent Sales Share by Application (2021-2032) Figure 62. Asia Pharma Sustained Release Agent Revenue Share by Country (2021-2032) Figure 63. Asia Pharma Sustained Release Agent Sales Share by Country (2021-2032) Figure 64. SAMEA Pharma Sustained Release Agent Revenue Share by Type (2021-2032) Figure 65. SAMEA Pharma Sustained Release Agent Sales Share by Type (2021-2032) Figure 66. SAMEA Pharma Sustained Release Agent Revenue Share by Application (2021-2032) Figure 67. SAMEA Pharma Sustained Release Agent Sales Share by Application (2021-2032) Figure 68. SAMEA Pharma Sustained Release Agent Revenue Share by Country (2021-2032) Figure 69. SAMEA Pharma Sustained Release Agent Sales Share by Country (2021-2032) Figure 70. Pharma Sustained Release Agent Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Pharma Sustained Release Agent Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Sugars
  • Gelatin
  • Minerals
  • Chitosan
  • Polymers
Applications
  • Pharmaceutical
  • Health Care
  • Others
Companies covered
  • Janssen Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Novartis AG
  • Merck KGaA
  • Mylan N.V.
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Valeant Pharmaceuticals International
  • Mayne Pharma Group
  • International Flavors & Fragrances
  • Gattefosse
  • Evonik Industries
  • Croda International
  • BASF
  • Ashland Global
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharma Sustained Release Agent Market by Type
  3. 1.2.1 Global Pharma Sustained Release Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sugars
  5. 1.2.3 Gelatin
  6. 1.2.4 Minerals
  7. 1.2.5 Chitosan
  8. 1.2.6 Polymers
  9. 1.3 Pharma Sustained Release Agent Market by Application
  10. 1.3.1 Global Pharma Sustained Release Agent Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical
  12. 1.3.3 Health Care
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Pharma Sustained Release Agent Market Dynamics
  1. 2.1 Pharma Sustained Release Agent Industry Trends
  2. 2.2 Pharma Sustained Release Agent Industry Drivers
  3. 2.3 Pharma Sustained Release Agent Industry Opportunities and Challenges
  4. 2.4 Pharma Sustained Release Agent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pharma Sustained Release Agent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pharma Sustained Release Agent Revenue by Region
  3. 3.2.1 Global Pharma Sustained Release Agent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharma Sustained Release Agent Revenue by Region (2021-2026)
  5. 3.2.3 Global Pharma Sustained Release Agent Revenue by Region (2027-2032)
  6. 3.2.4 Global Pharma Sustained Release Agent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pharma Sustained Release Agent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pharma Sustained Release Agent Sales by Region
  9. 3.4.1 Global Pharma Sustained Release Agent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pharma Sustained Release Agent Sales by Region (2021-2026)
  11. 3.4.3 Global Pharma Sustained Release Agent Sales by Region (2027-2032)
  12. 3.4.4 Global Pharma Sustained Release Agent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pharma Sustained Release Agent Revenue by Manufacturers
  2. 4.1.1 Global Pharma Sustained Release Agent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pharma Sustained Release Agent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pharma Sustained Release Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharma Sustained Release Agent Sales by Manufacturers
  6. 4.2.1 Global Pharma Sustained Release Agent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pharma Sustained Release Agent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pharma Sustained Release Agent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pharma Sustained Release Agent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pharma Sustained Release Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pharma Sustained Release Agent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pharma Sustained Release Agent Manufacturers, Product Type & Application
  13. 4.7 Global Pharma Sustained Release Agent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pharma Sustained Release Agent Market CR5 and HHI
  16. 4.8.2 2025 Pharma Sustained Release Agent Tier 1, Tier 2, and Tier 3
5 Pharma Sustained Release Agent Market by Type
  1. 5.1 Global Pharma Sustained Release Agent Revenue by Type
  2. 5.1.1 Global Pharma Sustained Release Agent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pharma Sustained Release Agent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pharma Sustained Release Agent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pharma Sustained Release Agent Sales by Type
  6. 5.2.1 Global Pharma Sustained Release Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharma Sustained Release Agent Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Pharma Sustained Release Agent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pharma Sustained Release Agent Price by Type
6 Pharma Sustained Release Agent Market by Application
  1. 6.1 Global Pharma Sustained Release Agent Revenue by Application
  2. 6.1.1 Global Pharma Sustained Release Agent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pharma Sustained Release Agent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pharma Sustained Release Agent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pharma Sustained Release Agent Sales by Application
  6. 6.2.1 Global Pharma Sustained Release Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pharma Sustained Release Agent Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Pharma Sustained Release Agent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pharma Sustained Release Agent Price by Application
7 Company Profiles
  1. 7.1 Janssen Pharmaceuticals
  2. 7.1.1 Janssen Pharmaceuticals Company Information
  3. 7.1.2 Janssen Pharmaceuticals Business Overview
  4. 7.1.3 Janssen Pharmaceuticals Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Pharmaceuticals Pharma Sustained Release Agent Product Portfolio
  6. 7.1.5 Janssen Pharmaceuticals Recent Developments
  7. 7.2 Teva Pharmaceutical Industries
  8. 7.2.1 Teva Pharmaceutical Industries Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Pharma Sustained Release Agent Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 7.3 Sun Pharmaceutical Industries
  14. 7.3.1 Sun Pharmaceutical Industries Company Information
  15. 7.3.2 Sun Pharmaceutical Industries Business Overview
  16. 7.3.3 Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Industries Pharma Sustained Release Agent Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 7.4 Novartis AG
  20. 7.4.1 Novartis AG Company Information
  21. 7.4.2 Novartis AG Business Overview
  22. 7.4.3 Novartis AG Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis AG Pharma Sustained Release Agent Product Portfolio
  24. 7.4.5 Novartis AG Recent Developments
  25. 7.5 Merck KGaA
  26. 7.5.1 Merck KGaA Company Information
  27. 7.5.2 Merck KGaA Business Overview
  28. 7.5.3 Merck KGaA Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck KGaA Pharma Sustained Release Agent Product Portfolio
  30. 7.5.5 Merck KGaA Recent Developments
  31. 7.6 Mylan N.V.
  32. 7.6.1 Mylan N.V. Company Information
  33. 7.6.2 Mylan N.V. Business Overview
  34. 7.6.3 Mylan N.V. Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mylan N.V. Pharma Sustained Release Agent Product Portfolio
  36. 7.6.5 Mylan N.V. Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Pharma Sustained Release Agent Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Pharma Sustained Release Agent Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 AstraZeneca
  50. 7.9.1 AstraZeneca Company Information
  51. 7.9.2 AstraZeneca Business Overview
  52. 7.9.3 AstraZeneca Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Pharma Sustained Release Agent Product Portfolio
  54. 7.9.5 AstraZeneca Recent Developments
  55. 7.10 Valeant Pharmaceuticals International
  56. 7.10.1 Valeant Pharmaceuticals International Company Information
  57. 7.10.2 Valeant Pharmaceuticals International Business Overview
  58. 7.10.3 Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Valeant Pharmaceuticals International Pharma Sustained Release Agent Product Portfolio
  60. 7.10.5 Valeant Pharmaceuticals International Recent Developments
  61. 7.11 Mayne Pharma Group
  62. 7.11.1 Mayne Pharma Group Company Information
  63. 7.11.2 Mayne Pharma Group Business Overview
  64. 7.11.3 Mayne Pharma Group Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Mayne Pharma Group Pharma Sustained Release Agent Product Portfolio
  66. 7.11.5 Mayne Pharma Group Recent Developments
  67. 7.12 International Flavors & Fragrances
  68. 7.12.1 International Flavors & Fragrances Company Information
  69. 7.12.2 International Flavors & Fragrances Business Overview
  70. 7.12.3 International Flavors & Fragrances Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 International Flavors & Fragrances Pharma Sustained Release Agent Product Portfolio
  72. 7.12.5 International Flavors & Fragrances Recent Developments
  73. 7.13 Gattefosse
  74. 7.13.1 Gattefosse Company Information
  75. 7.13.2 Gattefosse Business Overview
  76. 7.13.3 Gattefosse Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Gattefosse Pharma Sustained Release Agent Product Portfolio
  78. 7.13.5 Gattefosse Recent Developments
  79. 7.14 Evonik Industries
  80. 7.14.1 Evonik Industries Company Information
  81. 7.14.2 Evonik Industries Business Overview
  82. 7.14.3 Evonik Industries Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Evonik Industries Pharma Sustained Release Agent Product Portfolio
  84. 7.14.5 Evonik Industries Recent Developments
  85. 7.15 Croda International
  86. 7.15.1 Croda International Company Information
  87. 7.15.2 Croda International Business Overview
  88. 7.15.3 Croda International Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Croda International Pharma Sustained Release Agent Product Portfolio
  90. 7.15.5 Croda International Recent Developments
  91. 7.16 BASF
  92. 7.16.1 BASF Company Information
  93. 7.16.2 BASF Business Overview
  94. 7.16.3 BASF Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 BASF Pharma Sustained Release Agent Product Portfolio
  96. 7.16.5 BASF Recent Developments
  97. 7.17 Ashland Global
  98. 7.17.1 Ashland Global Company Information
  99. 7.17.2 Ashland Global Business Overview
  100. 7.17.3 Ashland Global Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Ashland Global Pharma Sustained Release Agent Product Portfolio
  102. 7.17.5 Ashland Global Recent Developments
  103. 7.18 Allergan
  104. 7.18.1 Allergan Company Information
  105. 7.18.2 Allergan Business Overview
  106. 7.18.3 Allergan Pharma Sustained Release Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Allergan Pharma Sustained Release Agent Product Portfolio
  108. 7.18.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Pharma Sustained Release Agent Market Size by Type
  2. 8.1.1 North America Pharma Sustained Release Agent Revenue by Type (2021-2032)
  3. 8.1.2 North America Pharma Sustained Release Agent Sales by Type (2021-2032)
  4. 8.1.3 North America Pharma Sustained Release Agent Price by Type (2021-2032)
  5. 8.2 North America Pharma Sustained Release Agent Market Size by Application
  6. 8.2.1 North America Pharma Sustained Release Agent Revenue by Application (2021-2032)
  7. 8.2.2 North America Pharma Sustained Release Agent Sales by Application (2021-2032)
  8. 8.2.3 North America Pharma Sustained Release Agent Price by Application (2021-2032)
  9. 8.3 North America Pharma Sustained Release Agent Market Size by Country
  10. 8.3.1 North America Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pharma Sustained Release Agent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pharma Sustained Release Agent Market Size by Type
  2. 9.1.1 Europe Pharma Sustained Release Agent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pharma Sustained Release Agent Sales by Type (2021-2032)
  4. 9.1.3 Europe Pharma Sustained Release Agent Price by Type (2021-2032)
  5. 9.2 Europe Pharma Sustained Release Agent Market Size by Application
  6. 9.2.1 Europe Pharma Sustained Release Agent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pharma Sustained Release Agent Sales by Application (2021-2032)
  8. 9.2.3 Europe Pharma Sustained Release Agent Price by Application (2021-2032)
  9. 9.3 Europe Pharma Sustained Release Agent Market Size by Country
  10. 9.3.1 Europe Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pharma Sustained Release Agent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pharma Sustained Release Agent Market Size by Type
  2. 10.1.1 China Pharma Sustained Release Agent Revenue by Type (2021-2032)
  3. 10.1.2 China Pharma Sustained Release Agent Sales by Type (2021-2032)
  4. 10.1.3 China Pharma Sustained Release Agent Price by Type (2021-2032)
  5. 10.2 China Pharma Sustained Release Agent Market Size by Application
  6. 10.2.1 China Pharma Sustained Release Agent Revenue by Application (2021-2032)
  7. 10.2.2 China Pharma Sustained Release Agent Sales by Application (2021-2032)
  8. 10.2.3 China Pharma Sustained Release Agent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharma Sustained Release Agent Market Size by Type
  2. 11.1.1 Asia Pharma Sustained Release Agent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pharma Sustained Release Agent Sales by Type (2021-2032)
  4. 11.1.3 Asia Pharma Sustained Release Agent Price by Type (2021-2032)
  5. 11.2 Asia Pharma Sustained Release Agent Market Size by Application
  6. 11.2.1 Asia Pharma Sustained Release Agent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pharma Sustained Release Agent Sales by Application (2021-2032)
  8. 11.2.3 Asia Pharma Sustained Release Agent Price by Application (2021-2032)
  9. 11.3 Asia Pharma Sustained Release Agent Market Size by Country
  10. 11.3.1 Asia Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pharma Sustained Release Agent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharma Sustained Release Agent Market Size by Type
  2. 12.1.1 SAMEA Pharma Sustained Release Agent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pharma Sustained Release Agent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pharma Sustained Release Agent Price by Type (2021-2032)
  5. 12.2 SAMEA Pharma Sustained Release Agent Market Size by Application
  6. 12.2.1 SAMEA Pharma Sustained Release Agent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pharma Sustained Release Agent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pharma Sustained Release Agent Price by Application (2021-2032)
  9. 12.3 SAMEA Pharma Sustained Release Agent Market Size by Country
  10. 12.3.1 SAMEA Pharma Sustained Release Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pharma Sustained Release Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pharma Sustained Release Agent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pharma Sustained Release Agent Value Chain Analysis
  2. 13.1.1 Pharma Sustained Release Agent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pharma Sustained Release Agent Production Mode & Process
  6. 13.2 Pharma Sustained Release Agent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pharma Sustained Release Agent Distributors
  9. 13.2.3 Pharma Sustained Release Agent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst